Learn how nanoparticles cross the blood-brain barrier (BBB) and explore their potential in treating neurological disorders ...
Novotech, a top global clinical trial provider, partners with biotech and pharma to speed siRNA therapeutic development.
ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA ...
Hosted on MSN22d
Combined organ-specific mRNA and lipid nanoparticle therapy could repair damaged lungs"While using other lipid nanoparticles works great to prevent infectious diseases, in addition to being specific to the lung, this new platform does not have to be stored at such extremely cold ...
Company is applying its T cell-selective lipid nanoparticle ... space for T cell-specific therapies.” Business Highlights Delivering siRNA with a T cell-selective LNP could enable selective modulation ...
The convergence of AI and drug delivery is opening new frontiers in precision medicine. AI-powered predictive modeling is ...
Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for ... creating a new application space for T cell-specific therapies." Business Highlights Applying T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback